C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,219 | +15.1% | 140,020 | +94.5% | 0.00% | 0.0% |
| Q1 2023 | $226,040 | -63.0% | 72,000 | -22.4% | 0.00% | 0.0% |
| Q4 2022 | $610,867 | +36.4% | 92,739 | +81.3% | 0.00% | -50.0% |
| Q3 2022 | $448,000 | -4.3% | 51,150 | -17.5% | 0.00% | 0.0% |
| Q2 2022 | $468,000 | +11.4% | 61,994 | +257.4% | 0.00% | 0.0% |
| Q1 2022 | $420,000 | +76.5% | 17,348 | +134.3% | 0.00% | +100.0% |
| Q4 2021 | $238,000 | -10.5% | 7,404 | +24.3% | 0.00% | 0.0% |
| Q3 2021 | $266,000 | +17.2% | 5,957 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $227,000 | – | 5,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |